HEMITARTARATO DE RIVASTIGMINA 1,5 MG CAP DURA CT BL AL PLAS TRANS X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1235202590136 -
GGREM
529920110069607 -
Código de barras
7897076922632
O que a fonte publica
- Detentor do registro
- RANBAXY FARMACÊUTICA LTDA
- Princípios ativos
- HEMITARTARATO DE RIVASTIGMINA
- Embalagem
- 1,5 MG CAP DURA CT BL AL PLAS TRANS X 30
- Regime de dispensação
- Tarja Vermelha sob restrição
- Tipo de produto
- Genérico
- Classe terapêutica
- N7D1 - PRODUTOS ANTIALZHEIMER, INIBIDORES DA COLINESTERASE
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
- HEMITARTARATO DE RIVASTIGMINA 1,5 MG CAP DURA CT BL AL PLAS TRANS X 30
- HEMITARTARATO DE RIVASTIGMINA
Dados completos da fonte
{
"name": "HEMITARTARATO DE RIVASTIGMINA 1,5 MG CAP DURA CT BL AL PLAS TRANS X 30",
"holder": "RANBAXY FARMACÊUTICA LTDA",
"stripe": "Tarja Vermelha sob restrição",
"barcodes": [
"7897076922632"
],
"confaz87": true,
"currency": "BRL",
"marketed": null,
"ggremCode": "529920110069607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "73.663.650/0001-90",
"priceRegime": "Regulado",
"productName": "HEMITARTARATO DE RIVASTIGMINA",
"productType": "Genérico",
"hospitalOnly": false,
"presentation": "1,5 MG CAP DURA CT BL AL PLAS TRANS X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha sob restrição",
"factoryPrices": {
"icms-0": "143.30",
"icms-12": "162.84",
"icms-17": "172.65",
"icms-18": "174.76",
"icms-19": "176.91",
"icms-20": "179.13",
"icms-21": "181.39",
"icms-22": "183.72",
"icms-23": "186.10",
"icms-17.5": "173.70",
"icms-19.5": "178.01",
"icms-20.5": "180.25",
"icms-22.5": "184.90",
"icms-12-alc": "160.89",
"icms-17-alc": "170.58",
"icms-18-alc": "172.66",
"icms-19-alc": "174.79",
"icms-20-alc": "176.98",
"icms-21-alc": "179.22",
"icms-22-alc": "181.51",
"icms-23-alc": "183.87",
"withoutTaxes": "141.58",
"icms-17.5-alc": "171.61",
"icms-19.5-alc": "175.88",
"icms-20.5-alc": "178.09",
"icms-22.5-alc": "182.68"
},
"pisCofinsList": "Positiva",
"substanceText": "HEMITARTARATO DE RIVASTIGMINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "197.52",
"icms-12": "224.46",
"icms-17": "237.98",
"icms-18": "240.89",
"icms-19": "243.85",
"icms-20": "246.91",
"icms-21": "250.03",
"icms-22": "253.24",
"icms-23": "256.52",
"icms-17.5": "239.43",
"icms-19.5": "245.37",
"icms-20.5": "248.46",
"icms-22.5": "254.87",
"icms-12-alc": "222.42",
"icms-17-alc": "235.82",
"icms-18-alc": "238.69",
"icms-19-alc": "241.64",
"icms-20-alc": "244.66",
"icms-21-alc": "247.76",
"icms-22-alc": "250.93",
"icms-23-alc": "254.19",
"withoutTaxes": "195.73",
"icms-17.5-alc": "237.24",
"icms-19.5-alc": "243.14",
"icms-20.5-alc": "246.20",
"icms-22.5-alc": "252.54"
},
"invalidBarcodes": [],
"activeSubstances": [
"HEMITARTARATO DE RIVASTIGMINA"
],
"therapeuticClass": "N7D1 - PRODUTOS ANTIALZHEIMER, INIBIDORES DA COLINESTERASE",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1235202590136",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "N7D1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:529920110069607"